Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -2.02EBITDA per Share
VS
Market
Sector
Industry
History
$ 11.92Close
$ 3.75 - $ 12.1 52-Week Range
Ticker Information
Ticker
ATXSCompany Name
ASTRIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQASTRIA THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ATXS - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -116.92M | $ -2.02 | 1 | 58.01M |
| 3/31/2025 | $ -108.04M | $ -1.86 | 1 | 58.01M |
| 12/31/2024 | $ -94.26M | $ -1.68 | 1 | 56.16M |
| 9/30/2024 | $ -100.04M | $ -1.73 | 1 | 57.82M |
| 6/30/2024 | $ -93.24M | $ -1.65 | 1 | 56.49M |
| 3/31/2024 | $ -81.63M | $ -1.56 | 1 | 52.29M |
| 12/31/2023 | $ -72.89M | $ -2.42 | 1 | 30.12M |
| 9/30/2023 | $ -54.74M | $ -1.95 | 1 | 28.04M |
| 6/30/2023 | $ -49.01M | $ -1.75 | 1 | 28.02M |
| 3/31/2023 | $ -47.7M | $ -1.71 | 1 | 27.94M |
Key Performance Insights, Last 5 Years
- ASTRIA THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -10.79.
- Over the past 5 years, ASTRIA THERAPEUTICS INC's average EBITDAPS has been $ -8.91.
- The median EBITDAPS for ASTRIA THERAPEUTICS INC during this period was $ -2.75
- ASTRIA THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ -1.56.
- The lowest EBITDAPS recorded by ASTRIA THERAPEUTICS INC in the same timeframe $ -53.47
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for ASTRIA THERAPEUTICS INC is calculated as follows: EBITDA [ $ -34.93M ] / (Shares WA [ 3.24M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -10.79 ] ATXS - EBITDA per Share, Last 5 years
$ -53.47
Minimum
Mar 31, 2021
$ -1.56
Maximum
Mar 31, 2024
$ -8.91
Average
$ -2.75
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 13.95 |
| average | $ 2.01 |
| median | $ 0.99 |
| std | $ 4.26 |